Sicart Associates LLC Novartis Ag Transaction History

Sicart Associates LLC

  • $272 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 12, 2018
SELL
$70.39 - $84.15 $1.62 Million - $1.94 Million
-23,000 Closed
0 $0
Q4 2017

Jan 17, 2018
SELL
$72.33 - $77.64 $1.66 Million - $1.79 Million
-23,000 Closed
0 $0
Q3 2017

Nov 06, 2017
BUY
$74.14 - $77.27 $1.71 Million - $1.78 Million
23,000
23,000 $1.98 Million

Others Institutions Holding NVS

# of Institutions
1,438
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $208B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Sicart Associates LLC Portfolio

Follow Sicart Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sicart Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sicart Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email